Friday, February 10, 2017 2:28:01 PM
ANALYTICS AT THE FOREFRONT OF PERSONALIZED MEDICINE
3D Signatures Inc. is a cutting edge diagnostic company that has developed over 20 years a proprietary software program that:
1. Diagnosis what kind of disease/cancer the patient has.
2. Gives a Prognosis of how stable or aggressive the disease is.
3. Determines how a patient will respond to a specific treatment.
4. Monitors whether the patient is stable during treatment.
5. The precise and predictive nature of 3D Signatures platform will generate huge savings for both the health care providers
as well as the patient all leading to speedier and better patient outcomes.
6. $20 million in successful R&D built into the company thus far.
7. 16 Clinical trials completed on over 1,500 patients.
8. 20 years of research.
9. 13 Cancers and Alzheimer's studied.
10. Several Big Pharma companies are monitoring 3D Signatures Inc
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM